CytoSorbents CFO Kathleen P. Bloch to retire March 31, 2023; consulting role planned

Cytosorbents Corp

CFO Bloch, age 68, will retire effective March 31, 2023, after 9+ years at CytoSorbents.
She will remain as a consultant post-retirement to assist with transition.
Company has initiated a search for a replacement CFO.
Bloch oversaw financings of over $140 million and helped up-list to Nasdaq.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Kathleen P. Bloch

Chief Financial Officer

CTSO · Cytosorbents Corp

Effective: 2023-03-31
Filed: October 6, 2022, 7:59 PM ET

On September 30, 2022, Ms. Kathleen P. Bloch notified CytoSorbents Corporation (the “Company”) and the Board of Directors (the “Board”) of her decision to retire from her role as Chief Financial Officer of the Company, effective as of March 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kathleen P. Bloch retired as Chief Financial Officer at Cytosorbents Corp.

Action: retired
Role: Chief Financial Officer

Exact text from the filing

On September 30, 2022, Ms. Kathleen P. Bloch notified CytoSorbents Corporation (the “Company”) and the Board of Directors (the “Board”) of her decision to retire from her role as Chief Financial Officer of the Company, effective as of March 31, 2023.

View on SEC.gov

Cytosorbents Corp filing history →

Source: SEC EDGAR

accession 0001104659-22-106813

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.